Glomerular disease: Addition of immunosuppression to supportive care does not STOP-IgAN

Nature Reviews Nephrology 12, 61 (2016). doi:10.1038/nrneph.2015.209 Author: Ellen F. Carney New data from the STOP-IgAN trial suggest that immunosuppressive treatment might not be beneficial in high-risk patients with IgA nephropathy (IgAN) who are receiving supportive care. This finding is in contrast to the results of previous studies that reported a potential benefit of immunosuppression in
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Tags: Research Highlight Source Type: research